Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Expression of eosinophil major basic protein and neutrophil elastase in nasal polyp tissue and secretion].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2008
Same author

[Effect of interferon-gamma on the expression of vascular endothelial growth factor C on Hep-2 laryngeal carcinoma cell lines].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2008
Same author

Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.

European journal of pharmacology·2008
Same author

[Inhibition of oxidative activity of myeloperoxidase by anti-myeloperoxidase antibodies from patients with microscopic polyangiitis].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2008
Same author

Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.

The journal of gene medicine·2008
Same author

[Ultrasonographic findings of intussusception complicated by intestinal necrosis in children].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2008
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2026

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies
06:08

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on: September 8, 2023

Sequential generalized likelihood ratio tests for vaccine safety evaluation.

Mei-Chiung Shih1, Tze Leung Lai, Joseph F Heyse

  • 1VA Palo Alto Cooperative Studies Program Coordinating Center, Mountain View, CA 94043, USA. meichiun@stanford.edu

Statistics in Medicine
|August 28, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces new sequential methods for vaccine safety analysis, enabling faster detection of adverse events in clinical trials. These advanced statistical approaches improve vaccine safety monitoring efficiency.

More Related Videos

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

Related Experiment Videos

Last Updated: Jun 9, 2026

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies
06:08

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on: September 8, 2023

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Vaccinology

Background:

  • Vaccine safety evaluation is crucial, involving pre-clinical, pre-licensure, and post-licensure studies.
  • Sequential designs offer advantages for early trial termination or rapid identification of adverse event rate exceedances.

Purpose of the Study:

  • To propose a novel class of sequential generalized likelihood ratio tests.
  • To evaluate adverse event rates in vaccine clinical trials and post-licensure studies.

Main Methods:

  • Review of recent developments in sequential analysis for vaccine safety.
  • Development and application of sequential generalized likelihood ratio tests.
  • Illustration using data from the Rotavirus Efficacy and Safety Trial and simulation studies.

Main Results:

  • The proposed sequential methods provide a robust framework for evaluating vaccine adverse event rates.
  • Simulation studies demonstrate the performance of the new approach compared to existing methods.

Conclusions:

  • The new sequential generalized likelihood ratio tests enhance the efficiency and safety monitoring of vaccine trials.
  • This approach offers a valuable tool for biostatisticians and researchers in vaccinology.